Trial Profile
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Gentamicin (Primary) ; Levofloxacin
- Indications Bacterial infections; Diabetic foot ulcer; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Acronyms COACT-1
- Sponsors Innocoll
- 02 Aug 2021 Status changed from active, no longer recruiting to completed.
- 03 Nov 2016 Results published in Innocoll Holdings plc media release.
- 03 Nov 2016 Primary endpoint has not been met. (Clinical Cure (Resolution of all clinical signs and symptoms of infection)), as per Innocoll Holdings plc media release.